FL-QSAR
FL-QSAR implements a federated learning-based Quantitative Structure-Activity Relationship (QSAR) framework to enable collaborative, privacy-preserving QSAR model training across multiple institutions.
Key Features:
- Horizontal Federated Learning (HFL): FL-QSAR employs horizontal federated learning (HFL) to enable collaborative QSAR modeling without direct sharing of raw data and can simulate scenarios with and without HFL.
- Privacy-Preserving Collaboration: The framework retains each institution's data locally to address intellectual property and financial concerns while allowing contribution to collective model training.
- Performance Enhancement: Experiments reported that collaboration through FL-QSAR improves QSAR prediction performance compared to using only private datasets and approaches the performance of shared-data methods.
- Comparison with Secure Multiparty Computation (MPC): FL-QSAR has been contrasted with secure multiparty computation frameworks, highlighting differences in efficiency and practicality for QSAR modeling tasks.
- Extensibility: The framework is designed to be adaptable to other deep learning algorithms for drug-related learning tasks beyond QSAR analysis.
Scientific Applications:
- Collaborative QSAR model development: Enables pharmaceutical institutions to jointly develop QSAR models while maintaining control over proprietary datasets.
- Drug discovery and candidate prioritization: Supports development of more accurate and robust QSAR models to accelerate identification of potential therapeutic compounds while safeguarding sensitive information.
Methodology:
Clients train models on local QSAR datasets and contribute model updates (not raw data), which are aggregated iteratively to update a global model.
Topics
Details
- License:
- Apache-2.0
- Tool Type:
- command-line tool, workflow
- Programming Languages:
- Python
- Added:
- 1/18/2021
- Last Updated:
- 3/11/2021
Operations
Publications
Chen S, Xue D, Chuai G, Yang Q, Liu Q. FL-QSAR: a federated learning based QSAR prototype for collaborative drug discovery. Unknown Journal. 2020. doi:10.1101/2020.02.27.950592.